These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 16144995)

  • 61. The transplanted liver graft is capable of clearing asymmetric dimethylarginine.
    Siroen MP; Warlé MC; Teerlink T; Nijveldt RJ; Kuipers EJ; Metselaar HJ; Tilanus HW; Kuik DJ; van der Sijp JR; Meijer S; van der Hoven B; van Leeuwen PA
    Liver Transpl; 2004 Dec; 10(12):1524-30. PubMed ID: 15558588
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Asymmetric dimethylarginine accumulates in the kidney during ischemia/reperfusion injury.
    Nakayama Y; Ueda S; Yamagishi S; Obara N; Taguchi K; Ando R; Kaida Y; Iwatani R; Kaifu K; Yokoro M; Toyonaga M; Kusumoto T; Fukami K; Okuda S
    Kidney Int; 2014 Mar; 85(3):570-8. PubMed ID: 24107853
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pioglitazone lowers systemic asymmetric dimethylarginine by inducing dimethylarginine dimethylaminohydrolase in rats.
    Wakino S; Hayashi K; Tatematsu S; Hasegawa K; Takamatsu I; Kanda T; Homma K; Yoshioka K; Sugano N; Saruta T
    Hypertens Res; 2005 Mar; 28(3):255-62. PubMed ID: 16097370
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Vascular endothelium is the organ chiefly responsible for the catabolism of plasma asymmetric dimethylarginine--an explanation for the elevation of plasma ADMA in disorders characterized by endothelial dysfunction.
    McCarty MF
    Med Hypotheses; 2004; 63(4):699-708. PubMed ID: 15325021
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cyclosporine treatment of high dose and long duration reduces the severity of graft coronary artery disease in rodent cardiac allografts.
    Lijkwan MA; Cooke DT; Martens JM; Kown MH; Murata S; Peterson SH; Hoyt EG; Robbins RC
    J Heart Lung Transplant; 2005 Apr; 24(4):439-45. PubMed ID: 15797746
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The L-arginine/NO pathway in end-stage liver disease and during orthotopic liver and kidney transplantation: biological and analytical ramifications.
    Becker T; Mevius I; de Vries DK; Schaapherder AF; zu Vilsendorf AM; Klempnauer J; Frölich JC; Tsikas D
    Nitric Oxide; 2009 Feb; 20(1):61-7. PubMed ID: 18948222
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Role of asymmetric dimethylarginine (ADMA) in diabetic vascular complications.
    Yamagishi S; Ueda S; Nakamura K; Matsui T; Okuda S
    Curr Pharm Des; 2008; 14(25):2613-8. PubMed ID: 18991678
    [TBL] [Abstract][Full Text] [Related]  

  • 68. S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase.
    Leiper J; Murray-Rust J; McDonald N; Vallance P
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13527-32. PubMed ID: 12370443
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Epigallocatechin gallate preserves endothelial function by reducing the endogenous nitric oxide synthase inhibitor level.
    Tang WJ; Hu CP; Chen MF; Deng PY; Li YJ
    Can J Physiol Pharmacol; 2006 Feb; 84(2):163-71. PubMed ID: 16900942
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Adenoviral-mediated overexpression of DDAH improves vascular tone regulation.
    Torondel B; Nandi M; Kelly P; Wojciak-Stothard B; Fleming I; Leiper J
    Vasc Med; 2010 Jun; 15(3):205-13. PubMed ID: 20219849
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Variance of DDAH/PRMT/ADMA pathway in atrial fibrillation dogs.
    Liu H; Qu X; Liang Z; Chen W; Xia W; Song Y
    Biochem Biophys Res Commun; 2008 Dec; 377(3):884-8. PubMed ID: 18951871
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase.
    Ito A; Tsao PS; Adimoolam S; Kimoto M; Ogawa T; Cooke JP
    Circulation; 1999 Jun; 99(24):3092-5. PubMed ID: 10377069
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Dimethylarginine dimethylaminohydrolase overexpression ameliorates atherosclerosis in apolipoprotein E-deficient mice by lowering asymmetric dimethylarginine.
    Jacobi J; Maas R; Cardounel AJ; Arend M; Pope AJ; Cordasic N; Heusinger-Ribeiro J; Atzler D; Strobel J; Schwedhelm E; Böger RH; Hilgers KF
    Am J Pathol; 2010 May; 176(5):2559-70. PubMed ID: 20348244
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dimethylarginine dimethylaminohydrolase1 is an organ-specific mediator of end organ damage in a murine model of hypertension.
    Sydow K; Schmitz C; von Leitner EC; von Leitner R; Klinke A; Atzler D; Krebs C; Wieboldt H; Ehmke H; Schwedhelm E; Meinertz T; Blankenberg S; Böger RH; Magnus T; Baldus S; Wenzel U
    PLoS One; 2012; 7(10):e48150. PubMed ID: 23110194
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of adenoviral up-regulation of bcl-2 on oxidative stress and graft coronary artery disease in rat heart transplants.
    Miniati DN; Lijkwan MA; Murata S; Martens J; Coleman CT; Hoyt EG; Robbins RC
    Transplantation; 2003 Jul; 76(2):382-6. PubMed ID: 12883197
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dimethylarginine dimethylaminohydrolase-2 overexpression improves impaired nitric oxide synthesis of endothelial cells induced by glycated protein.
    Lu CW; Xiong Y; He P
    Nitric Oxide; 2007 Feb; 16(1):94-103. PubMed ID: 16979918
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of asymmetric dimethylarginine (ADMA) on heart failure development.
    Liu X; Hou L; Xu D; Chen A; Yang L; Zhuang Y; Xu Y; Fassett JT; Chen Y
    Nitric Oxide; 2016 Apr; 54():73-81. PubMed ID: 26923818
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A stable-isotope based technique for the determination of dimethylarginine dimethylaminohydrolase (DDAH) activity in mouse tissue.
    Maas R; Tan-Andreesen J; Schwedhelm E; Schulze F; Böger RH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 851(1-2):220-8. PubMed ID: 17296339
    [TBL] [Abstract][Full Text] [Related]  

  • 79. DDAH2 alleviates myocardial fibrosis in diabetic cardiomyopathy through activation of the DDAH/ADMA/NOS/NO pathway in rats.
    Zhu ZD; Ye JM; Fu XM; Wang XC; Ye JY; Wu XR; Hua P; Liao YQ; Xuan W; Duan JL; Li WY; Fu H; Xia ZH; Zhang X
    Int J Mol Med; 2019 Feb; 43(2):749-760. PubMed ID: 30569164
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Role of endogenous nitric oxide synthase inhibitor in gastric mucosal injury.
    Wang L; Zhou Y; Peng J; Zhang Z; Jiang DJ; Li YJ
    Can J Physiol Pharmacol; 2008 Mar; 86(3):97-104. PubMed ID: 18418436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.